Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 490

1.

Anti-breast Cancer Enhancement of a Polysaccharide From Spore of Ganoderma lucidum With Paclitaxel: Suppression on Tumor Metabolism With Gut Microbiota Reshaping.

Su J, Li D, Chen Q, Li M, Su L, Luo T, Liang D, Lai G, Shuai O, Jiao C, Wu Q, Xie Y, Zhou X.

Front Microbiol. 2018 Dec 17;9:3099. doi: 10.3389/fmicb.2018.03099. eCollection 2018.

2.

Effect and Mechanism of Ganoderma lucidum Polysaccharides on Human Fibroblasts and Skin Wound Healing in Mice.

Hu F, Yan Y, Wang CW, Liu Y, Wang JJ, Zhou F, Zeng QH, Zhou X, Chen J, Wang AJ, Zhou JD.

Chin J Integr Med. 2018 Dec 15. doi: 10.1007/s11655-018-3060-9. [Epub ahead of print]

PMID:
30552545
3.

Ganoderma lucidum extract (GLE) impairs breast cancer stem cells by targeting the STAT3 pathway.

Rios-Fuller TJ, Ortiz-Soto G, Lacourt-Ventura M, Maldonado-Martinez G, Cubano LA, Schneider RJ, Martinez-Montemayor MM.

Oncotarget. 2018 Nov 13;9(89):35907-35921. doi: 10.18632/oncotarget.26294. eCollection 2018 Nov 13.

4.

(±) Gancochlearols A and B: cytotoxic and COX-2 inhibitory meroterpenoids from Ganoderma cochlear.

Qin FY, Yan YM, Tu ZC, Cheng YX.

Nat Prod Res. 2018 Dec 5:1-7. doi: 10.1080/14786419.2018.1531859. [Epub ahead of print]

PMID:
30518262
5.

Phytochemical composition, antioxidant and antiproliferative activities and effects on nuclear DNA of ethanolic extract from an Italian mycelial isolate of Ganoderma lucidum.

Saltarelli R, Palma F, Gioacchini AM, Calcabrini C, Mancini U, De Bellis R, Stocchi V, Potenza L.

J Ethnopharmacol. 2019 Mar 1;231:464-473. doi: 10.1016/j.jep.2018.11.041. Epub 2018 Dec 1.

PMID:
30513345
6.

Antioxidant potential of ganoderic acid in Notch-1 protein in neuroblastoma.

Gill BS, Navgeet, Kumar S.

Mol Cell Biochem. 2018 Dec 3. doi: 10.1007/s11010-018-3485-7. [Epub ahead of print]

PMID:
30511344
7.

Anticancer, antithrombotic, antityrosinase, and anti-α-glucosidase activities of selected wild and commercial mushrooms from Pakistan.

Sharif S, Atta A, Huma T, Shah AA, Afzal G, Rashid S, Shahid M, Mustafa G.

Food Sci Nutr. 2018 Sep 14;6(8):2170-2176. doi: 10.1002/fsn3.781. eCollection 2018 Nov.

8.

Ganoderma immunomodulatory protein and chidamide down-regulate integrin-related signaling pathway result in migration inhibition and apoptosis induction.

Lu CT, Leong PY, Hou TY, Huang SJ, Hsiao YP, Ko JL.

Phytomedicine. 2018 Dec 1;51:39-47. doi: 10.1016/j.phymed.2018.06.023. Epub 2018 Jun 23.

PMID:
30466626
9.

Ganoderma tsugae induced ROS-independent apoptosis and cytoprotective autophagy in human chronic myeloid leukemia cells.

Hseu YC, Shen YC, Kao MC, Mathew DC, Karuppaiya P, Li ML, Yang HL.

Food Chem Toxicol. 2018 Nov 19;124:30-44. doi: 10.1016/j.fct.2018.11.043. [Epub ahead of print]

PMID:
30465897
10.

Effective cancer immunotherapy by Ganoderma lucidum polysaccharide-gold nanocomposites through dendritic cell activation and memory T cell response.

Zhang S, Pang G, Chen C, Qin J, Yu H, Liu Y, Zhang X, Song Z, Zhao J, Wang F, Wang Y, Zhang LW.

Carbohydr Polym. 2019 Feb 1;205:192-202. doi: 10.1016/j.carbpol.2018.10.028. Epub 2018 Oct 13.

PMID:
30446095
11.

Ganoderma: A Cancer Immunotherapy Review.

Cao Y, Xu X, Liu S, Huang L, Gu J.

Front Pharmacol. 2018 Oct 25;9:1217. doi: 10.3389/fphar.2018.01217. eCollection 2018. Review.

12.

Ganoderic acid A exerts antitumor activity against MDA-MB-231 human breast cancer cells by inhibiting the Janus kinase 2/signal transducer and activator of transcription 3 signaling pathway.

Yang Y, Zhou H, Liu W, Wu J, Yue X, Wang J, Quan L, Liu H, Guo L, Wang Z, Lian X, Zhang Q.

Oncol Lett. 2018 Nov;16(5):6515-6521. doi: 10.3892/ol.2018.9475. Epub 2018 Sep 21.

13.

Ganoderma lucidum-derived polysaccharide enhances coix oil-based microemulsion on stability and lung cancer-targeted therapy.

Guo J, Yuan C, Huang M, Liu Y, Chen Y, Liu C, Chen Y.

Drug Deliv. 2018 Nov;25(1):1802-1810. doi: 10.1080/10717544.2018.1516006.

14.

Protection against Gut Inflammation and Sepsis in Mice by the Autodigested Product of the Lingzhi Medicinal Mushroom, Ganoderma lingzhi (Agaricomycetes).

Ishimoto Y, Ishibashi KI, Yamanaka D, Adachi Y, Ito H, Igami K, Miyazaki T, Ohno N.

Int J Med Mushrooms. 2018;20(9):809-823. doi: 10.1615/IntJMedMushrooms.2018027359.

PMID:
30317976
15.

Lingzhi or Reishi Medicinal Mushroom, Ganoderma lucidum (Agaricomycetes), Prevents Doxorubicin-Induced Cardiotoxicity in Rats.

Veena RK, Ajith TA, Janardhanan KK.

Int J Med Mushrooms. 2018;20(8):761-774. doi: 10.1615/IntJMedMushrooms.2018027010.

PMID:
30317952
16.

Ganoderma tsugae Inhibits the SREBP-1/AR Axis Leading to Suppression of Cell Growth and Activation of Apoptosis in Prostate Cancer Cells.

Huang SY, Huang GJ, Wu HC, Kao MC, Huang WC.

Molecules. 2018 Oct 5;23(10). pii: E2539. doi: 10.3390/molecules23102539.

17.

Effects of non-steroidal anti-inflammatory drug-activated gene-1 on Ganoderma lucidum polysaccharides-induced apoptosis of human prostate cancer PC-3 cells.

Wu K, Na K, Chen D, Wang Y, Pan H, Wang X.

Int J Oncol. 2018 Dec;53(6):2356-2368. doi: 10.3892/ijo.2018.4578. Epub 2018 Sep 28.

18.

Lanostane triterpenoids from Ganoderma luteomarginatum and their cytotoxicity against four human cancer cell lines.

Su HG, Zhou QM, Guo L, Huang YJ, Peng C, Xiong L.

Phytochemistry. 2018 Dec;156:89-95. doi: 10.1016/j.phytochem.2018.09.003. Epub 2018 Sep 18.

PMID:
30240975
19.

From nutraceutical to clinical trial: frontiers in Ganoderma development.

Hsu KD, Cheng KC.

Appl Microbiol Biotechnol. 2018 Nov;102(21):9037-9051. doi: 10.1007/s00253-018-9326-5. Epub 2018 Sep 4. Review.

PMID:
30182215
20.

Antitumor Activity of Extract From the Sporoderm-Breaking Spore of Ganoderma lucidum: Restoration on Exhausted Cytotoxic T Cell With Gut Microbiota Remodeling.

Su J, Su L, Li D, Shuai O, Zhang Y, Liang H, Jiao C, Xu Z, Lai Y, Xie Y.

Front Immunol. 2018 Jul 31;9:1765. doi: 10.3389/fimmu.2018.01765. eCollection 2018.

Supplemental Content

Loading ...
Support Center